Back to search
FDAFDA · Food and drugs·Recall number Z-1571-2023

PDS® Plus Antibacterial (polydioxanone) Suture - PDS PLUS CLR 27IN(70CM) USP3-0(M2) S/A PC-25 PRIME. Intended for use in general soft tissue approximation, including use in pediatric cardiovascular tissue. Product Code: PDP9625H

Published May 17, 2023 · Recall initiated: March 31, 2023

Summary

FDA records medical device Class II recall Z-1571-2023, published May 17, 2023 and initiated March 31, 2023. Recalling firm: Ethicon, Inc.; Status: Ongoing; Reported quantity: 1,656 eaches (OUS only); Lot: UDI-DI: (01)10705031124691 Primary (Individual Unit); (01)30705031124695 (Sales Unit Box) Qty = 36 eaches. Lot Number: SCMAZH. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Suture breakage during intra-operative use could result in poor performance of the impacted product because the intended benefit of tissue approximation and/or ligation may not be achieved

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ethicon, Inc.
Distributor
International distribution in the countries of United Kingdom, Ireland and Turkey.
Lot
UDI-DI: (01)10705031124691 Primary (Individual Unit); (01)30705031124695 (Sales Unit Box) Qty = 36 eaches. Lot Number: SCMAZH
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was PDS® Plus Antibacterial (polydioxanone) Suture - PDS PLUS CLR 27IN(70CM) USP3-0(M2) S/A PC-25 PRIME. Intended for use in general soft tissue approximation, including use in pediatric cardiovascular tissue. Product Code: PDP9625H recalled?

Yes. FDA published recall Z-1571-2023 on May 17, 2023. Reported hazard: Suture breakage during intra-operative use could result in poor performance of the impacted product because the intended benefit of tissue approximation and/or ligation may not be achieved

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail